Job SummaryThe Associate Director, Marketing will own the pre-launch brand foundation for cemsidomide: market definition, positioning, and early launch planning in multiple myeloma. You will work hands-on, translating clinical data into a clear strategic story and partnering closely with Medical Affairs, Clinical Development, Market Access, and Corporate Communications. As cemsidomide is investigational, all external activity will be non-promotional and compliant with pre-approval guidelines.
This is an exciting opportunity for someone equally comfortable designing a marketing campaign and running a physician advisory board to get in on the ground level of our commercial build out at C4T. Your skills and passion for this space will allow you to have a front row seat to see what it looks like to build out a commercial function at a small life sciences company as one of our first dedicated commercial hires.
Your RoleMessaging Development
- Lead development of disease-state and messaging for multiple myeloma, translating clinical data into clear, compliant narratives.
- Run message testing with hematologist-oncologists, community oncologists, and other customers; refine messages as data mature.
- Build and maintain the core messaging platform and ensure consistent use across venues and audiences.
- Take materials through Medical/Legal/Regulatory review with a clear grasp of pre-approval compliance.
Agency of Record (AOR) Selection and Onboarding
- Lead the search for C4T's first marketing AOR: define requirements, build the RFP, run pitches, and recommend a partner.
- Onboard the selected agency: brief them on the disease area, science, and compliance expectations; set up ways of working, review cadence, and scopes of work.
- Manage the agency day to day, including budgets, timelines, and quality of deliverables.
Advisory Boards
- Plan and run advisory boards with KOLs and community physicians, in partnership with Medical Affairs, to gather customer insights.
- Set objectives, design discussion guides, select participants, and manage logistics with vendors.
- Synthesize findings into clear recommendations and share them with cross-functional and senior leadership.
Competitive Intelligence
- Track the MM landscape, including next-generation IKZF1/3 degraders, BCMA- and GPRC5D-directed bispecifics, CAR-T, and anti-CD38 regimens.
- Lead congress coverage and competitive readouts at key meetings.
- Deliver regular competitive intelligence updates and assess implications for Cemsidomide's development and messaging.
Congress Booth Presence
- Own C4T's corporate and disease-awareness booth presence at major hematology and oncology congresses.
- Lead booth concept, design, and content with the AOR, medical affairs and exhibit vendors, ensuring all content is non-promotional and approved.
- Manage booth logistics, staffing, budget, and post-congress performance reviews.
Your BackgroundRequired:
- A Bachelor's Degree in life sciences, business, or a related field with a minimum of eight years in the pharmaceutical or biotechnology space, including at least five years in product or brand marketing, including oncology marketing experience.
- Hands-on experience turning corporate and departmental strategy into marketing execution with a strong sense of independence.
- Working knowledge of pre-approval compliance and the Medical/Legal/Regulatory review process.
- Ability to read and communicate clinical trial data with accuracy and confidence.
Preferred
- MBA or advanced scientific degree (PharmD, PhD, MS).
- Hematologic malignancies experience strong preferred, including multiple myeloma experience, ideally on a launch or pre-launch team.
- Experience at a small or emerging biotech building processes from scratch.
- Familiarity with the healthcare professional community
CompensationThe base pay range for this position at commencement of employment is expected to be between $199,104.00 - $219,500.00 annually; however, base pay offered may vary depending on multiple individualized factors, including job-related knowledge, skills, and experience.
